| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| 5-hydroxytryptamine receptor 2C | 0 | 8 | 1 | 10 |
| 5-hydroxytryptamine receptor 2A | 0 | 8 | 1 | 9 |
| 5-hydroxytryptamine receptor 1A | 0 | 25 | 4 | 30 |
| 5-hydroxytryptamine receptor 1B | 0 | 17 | 1 | 18 |
| 5-hydroxytryptamine receptor 1D | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 1F | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2B | 0 | 7 | 1 | 8 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| Sodium-dependent serotonin transporter | 0 | 18 | 3 | 21 |
| Sodium-dependent serotonin transporter | 0 | 7 | 0 | 7 |
| 5-hydroxytryptamine receptor 7 | 0 | 5 | 1 | 6 |
| 5-hydroxytryptamine receptor 5A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 5B | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 1 | 3 |
| Chain A, Beta-lactamase | 10 | 0 | 0 | 10 |
| Luciferase | 6 | 0 | 0 | 6 |
| glp-1 receptor, partial | 8 | 0 | 0 | 8 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 24 | 0 | 0 | 24 |
| ATAD5 protein, partial | 11 | 0 | 0 | 11 |
| Fumarate hydratase | 6 | 0 | 0 | 6 |
| TDP1 protein | 30 | 0 | 0 | 30 |
| GLI family zinc finger 3 | 24 | 0 | 0 | 24 |
| AR protein | 31 | 0 | 0 | 31 |
| caspase 7, apoptosis-related cysteine protease | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 20 | 0 | 0 | 20 |
| progesterone receptor | 16 | 0 | 0 | 16 |
| glucocorticoid receptor [Homo sapiens] | 29 | 0 | 0 | 29 |
| retinoic acid nuclear receptor alpha variant 1 | 24 | 0 | 0 | 24 |
| retinoid X nuclear receptor alpha | 19 | 0 | 0 | 19 |
| estrogen-related nuclear receptor alpha | 27 | 0 | 0 | 27 |
| farnesoid X nuclear receptor | 13 | 0 | 0 | 13 |
| pregnane X nuclear receptor | 24 | 0 | 0 | 24 |
| estrogen nuclear receptor alpha | 34 | 0 | 0 | 34 |
| polyprotein | 6 | 0 | 0 | 6 |
| 67.9K protein | 9 | 0 | 0 | 9 |
| peroxisome proliferator activated receptor gamma | 21 | 0 | 0 | 21 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 17 | 0 | 0 | 17 |
| caspase-3 | 5 | 0 | 0 | 5 |
| IDH1 | 11 | 0 | 0 | 11 |
| euchromatic histone-lysine N-methyltransferase 2 | 27 | 0 | 0 | 27 |
| aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 15 | 0 | 0 | 15 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| cellular tumor antigen p53 isoform a | 6 | 0 | 0 | 6 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
| chromobox protein homolog 1 | 21 | 0 | 0 | 21 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| transcriptional regulator ERG isoform 3 | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform 2 | 25 | 0 | 0 | 25 |
| histone deacetylase 9 isoform 3 | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| geminin | 23 | 0 | 0 | 23 |
| Vif | 0 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 13 | 0 | 0 | 13 |
| survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
| muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 27 | 0 | 0 | 27 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 29 | 0 | 29 |
| Multidrug resistance-associated protein 4 | 0 | 30 | 0 | 32 |
| Voltage-dependent calcium channel gamma-2 subunit | 11 | 0 | 0 | 11 |
| Bile salt export pump | 0 | 40 | 0 | 40 |
| Interferon beta | 17 | 0 | 0 | 17 |
| Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
| Integrin beta-3 | 5 | 1 | 0 | 6 |
| Integrin alpha-IIb | 5 | 1 | 0 | 6 |
| Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 11 | 0 | 0 | 11 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 8 | 0 | 0 | 8 |
| Canalicular multispecific organic anion transporter 1 | 0 | 26 | 0 | 26 |
| ATPase family AAA domain-containing protein 5 | 9 | 0 | 0 | 9 |
| Ataxin-2 | 17 | 0 | 0 | 17 |
| thioredoxin reductase | 19 | 0 | 0 | 19 |
| USP1 protein, partial | 18 | 0 | 0 | 18 |
| Microtubule-associated protein tau | 12 | 0 | 0 | 12 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| NFKB1 protein, partial | 6 | 0 | 0 | 6 |
| GLS protein | 14 | 0 | 0 | 14 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 19 | 0 | 0 | 19 |
| cytochrome P450 2D6 | 16 | 0 | 0 | 16 |
| arylsulfatase A | 13 | 0 | 0 | 13 |
| cytochrome P450 2D6 isoform 1 | 13 | 0 | 0 | 13 |
| D(1A) dopamine receptor | 12 | 0 | 0 | 12 |
| atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
| serine/threonine-protein kinase mTOR isoform 1 | 7 | 0 | 0 | 7 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 23 | 0 | 0 | 23 |
| muscarinic acetylcholine receptor M1 | 14 | 0 | 0 | 14 |
| Solute carrier family 22 member 1 | 0 | 18 | 0 | 20 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 0 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 9 | 0 | 9 |
| 5-hydroxytryptamine receptor 4 | 0 | 20 | 0 | 20 |
| Albumin | 0 | 0 | 7 | 7 |
| High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 10 | 0 | 10 |
| Muscarinic acetylcholine receptor M2 | 0 | 13 | 2 | 18 |
| Muscarinic acetylcholine receptor M4 | 0 | 13 | 1 | 16 |
| Muscarinic acetylcholine receptor M1 | 0 | 10 | 1 | 13 |
| Muscarinic acetylcholine receptor M3 | 0 | 9 | 1 | 12 |
| Muscarinic acetylcholine receptor M4 | 0 | 9 | 1 | 12 |
| Muscarinic acetylcholine receptor M5 | 0 | 10 | 1 | 13 |
| Muscarinic acetylcholine receptor M5 | 0 | 13 | 1 | 16 |
| Alpha-2A adrenergic receptor | 0 | 19 | 5 | 26 |
| Muscarinic acetylcholine receptor M2 | 0 | 10 | 2 | 15 |
| Muscarinic acetylcholine receptor M1 | 0 | 15 | 2 | 20 |
| Angiotensin-converting enzyme | 0 | 9 | 0 | 9 |
| D(2) dopamine receptor | 0 | 16 | 4 | 23 |
| Alpha-2B adrenergic receptor | 0 | 16 | 4 | 22 |
| Alpha-2C adrenergic receptor | 0 | 17 | 4 | 23 |
| Muscarinic acetylcholine receptor M3 | 0 | 13 | 2 | 17 |
| D(1A) dopamine receptor | 0 | 11 | 1 | 14 |
| D(1B) dopamine receptor | 0 | 4 | 0 | 6 |
| UDP-glucuronosyltransferase 1A4 | 0 | 3 | 0 | 7 |
| Sodium-dependent noradrenaline transporter | 0 | 12 | 1 | 13 |
| Histamine H2 receptor | 0 | 10 | 0 | 10 |
| Alpha-1D adrenergic receptor | 0 | 18 | 3 | 22 |
| 5-hydroxytryptamine receptor 2A | 0 | 19 | 2 | 21 |
| 5-hydroxytryptamine receptor 2C | 0 | 21 | 2 | 23 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Histamine H1 receptor | 0 | 14 | 0 | 14 |
| D(3) dopamine receptor | 0 | 13 | 1 | 17 |
| Sodium channel protein type 1 subunit alpha | 0 | 6 | 0 | 6 |
| Sodium channel protein type 4 subunit alpha | 0 | 8 | 0 | 10 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 18 | 1 | 19 |
| Alpha-1A adrenergic receptor | 0 | 12 | 4 | 16 |
| Histamine H2 receptor | 13 | 2 | 0 | 18 |
| D(1A) dopamine receptor | 6 | 1 | 0 | 7 |
| 5-hydroxytryptamine receptor 6 | 0 | 14 | 1 | 15 |
| 5-hydroxytryptamine receptor 7 | 0 | 12 | 0 | 12 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 5 | 0 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 9 | 0 | 9 |
| Sodium-dependent dopamine transporter | 0 | 8 | 0 | 8 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 22 | 0 | 22 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 9 | 0 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 10 | 0 | 10 |
| Sodium channel protein type 5 subunit alpha | 0 | 9 | 0 | 9 |
| Sodium channel protein type 9 subunit alpha | 0 | 9 | 0 | 9 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 8 | 0 | 8 |
| Sodium channel protein type 2 subunit alpha | 0 | 6 | 0 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 20 | 1 | 21 |
| Sodium channel protein type 3 subunit alpha | 0 | 7 | 0 | 7 |
| Sodium channel protein type 11 subunit alpha | 0 | 5 | 0 | 5 |
| Sodium channel protein type 8 subunit alpha | 0 | 5 | 0 | 5 |
| Histamine H3 receptor | 0 | 2 | 0 | 2 |
| Sodium channel protein type 10 subunit alpha | 0 | 5 | 0 | 5 |
| Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 13 | 0 | 0 | 13 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 12 | 0 | 0 | 12 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 17 | 1 | 3 | 21 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 13 | 0 | 0 | 13 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 8 | 0 | 0 | 8 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 8 | 0 | 0 | 8 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 16 | 0 | 0 | 16 |
| thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
| glucocerebrosidase | 5 | 0 | 0 | 5 |
| peroxisome proliferator-activated receptor delta | 11 | 0 | 0 | 11 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 6 | 0 | 6 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 9 | 0 | 10 |
| Carbonic anhydrase 2 | 0 | 9 | 1 | 11 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Adenosine receptor A1 | 0 | 6 | 0 | 8 |
| Adenosine receptor A2a | 0 | 4 | 2 | 10 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 7 | 0 | 0 | 7 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 12 | 6 | 3 | 21 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 1 | 5 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 3 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| SMAD family member 2 | 8 | 0 | 0 | 8 |
| SMAD family member 3 | 8 | 0 | 0 | 8 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
| G | 15 | 0 | 0 | 15 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| cytochrome P450 2C9 precursor | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform a | 8 | 0 | 0 | 8 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 12 | 0 | 0 | 12 |
| G-protein coupled receptor 35 isoform a | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 55 | 0 | 2 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit pi | 12 | 5 | 3 | 20 |
| HLA class I histocompatibility antigen, B alpha chain | 15 | 0 | 0 | 15 |
| Cytochrome P450 2C9 | 0 | 17 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit delta | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 12 | 5 | 3 | 20 |
| Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
| Kappa-type opioid receptor | 0 | 13 | 3 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 12 | 5 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 12 | 5 | 3 | 20 |
| GABA theta subunit | 12 | 5 | 3 | 20 |
| Inositol hexakisphosphate kinase 1 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit epsilon | 12 | 5 | 3 | 20 |
| cytochrome P450 2C9, partial | 15 | 0 | 0 | 15 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 10 | 0 | 0 | 10 |
| vitamin D3 receptor isoform VDRA | 9 | 0 | 0 | 9 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
| ATP-dependent translocase ABCB1 | 0 | 15 | 1 | 29 |
| Beta-1 adrenergic receptor | 0 | 6 | 2 | 8 |
| Cytochrome P450 3A4 | 0 | 9 | 1 | 12 |
| 5-hydroxytryptamine receptor 1A | 0 | 8 | 0 | 8 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| D | 0 | 9 | 0 | 9 |
| D(3) dopamine receptor | 0 | 11 | 0 | 11 |
| Alpha-2B adrenergic receptor | 0 | 10 | 3 | 13 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 10 | 3 | 13 |
| Alpha-2A adrenergic receptor | 0 | 10 | 3 | 13 |
| D(1B) dopamine receptor | 0 | 9 | 0 | 9 |
| D(4) dopamine receptor | 0 | 9 | 0 | 9 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| D(2) dopamine receptor | 0 | 11 | 1 | 13 |
| ATP-dependent phosphofructokinase | 10 | 0 | 0 | 10 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
| atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
| Potassium channel subfamily K member 2 | 0 | 5 | 5 | 10 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 3 | 3 | 6 |
| Adenosine receptor A3 | 0 | 3 | 1 | 4 |
| Replicase polyprotein 1ab | 0 | 3 | 3 | 6 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 5 | 4 | 11 |
| Adenosine receptor A2b | 0 | 2 | 0 | 4 |
| Adenosine receptor A2b | 0 | 3 | 1 | 6 |
| Adenosine receptor A1 | 0 | 3 | 2 | 9 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 2 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 3 | 0 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 2 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 2 |
| Chitotriosidase-1 | 0 | 2 | 0 | 2 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 3 | 4 |
| Endochitinase B1 | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 1 | 6 |
| Guanine deaminase | 0 | 2 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 13 | 0 | 13 |
| Major prion protein | 0 | 0 | 5 | 5 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 4 | 0 | 6 |
| Cytochrome P450 2B6 | 0 | 4 | 1 | 5 |
| Cytochrome P450 2J2 | 0 | 10 | 0 | 10 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 8 | 0 | 0 | 8 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 7 | 0 | 0 | 7 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 4 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 3 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| cytochrome P450 2C19 precursor | 8 | 0 | 0 | 8 |
| UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 2B10 | 0 | 3 | 0 | 3 |
| nonstructural protein 1 | 5 | 0 | 0 | 5 |
| ORF73 | 0 | 0 | 1 | 1 |
| Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
| Thrombopoietin | 4 | 0 | 0 | 4 |
| Smad3 | 4 | 0 | 0 | 4 |
| NADPH oxidase 1 | 0 | 1 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 3 |
| Adenylate cyclase type 1 | 0 | 3 | 0 | 3 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Spike glycoprotein | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
| caspase-3 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 9 | 0 | 0 | 9 |
| Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 1 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Albumin | 0 | 3 | 7 | 11 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 2 | 1 | 5 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1a | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
| Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 2 | 1 | 3 |
| Cytochrome P450 2D6 | 0 | 10 | 1 | 11 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 11 | 3 | 14 |
| Sphingomyelin phosphodiesterase | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 5 | 1 | 9 |
| Adenylate cyclase type 3 | 0 | 3 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 11 | 3 | 15 |
| Sodium-dependent dopamine transporter | 0 | 7 | 0 | 7 |
| Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 4 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
| Trypanothione reductase | 0 | 4 | 0 | 4 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 3 | 0 | 6 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 1 | 5 |
| Mu-type opioid receptor | 0 | 14 | 6 | 21 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 8 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 10 | 2 | 13 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
| Calmodulin | 0 | 1 | 1 | 2 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 6 | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 5 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 3 |
| Adenylyl cyclase 7 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 3 |
| D | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 3 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Transporter | 0 | 4 | 0 | 4 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 3 | 5 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 5 |
| Alpha-1A adrenergic receptor | 0 | 5 | 4 | 10 |
| Alpha-1B adrenergic receptor | 0 | 4 | 3 | 8 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 6 | 0 | 6 |
| Nischarin | 0 | 2 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
| Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 5 | 0 | 6 |
| Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
| Dihydrofolate reductase | 0 | 3 | 0 | 3 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 2 | 2 | 4 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Steryl-sulfatase | 0 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 6 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 4 |
| Gamma-aminobutyric acid | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 4 | 0 | 4 |
| Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 4 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 4 | 2 | 6 |
| Translocator protein | 0 | 1 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 4 | 1 | 5 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 4 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
| Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 4 |
| Parkin | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
| ATP-binding cassette sub-family C member 9 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| ATP synthase subunit beta, mitochondrial | 0 | 1 | 0 | 1 |
| ATP synthase subunit delta, mitochondrial | 0 | 1 | 0 | 1 |
| ATP synthase subunit gamma, mitochondrial | 0 | 1 | 0 | 1 |
| ATP synthase subunit epsilon, mitochondrial | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 8 | 0 | 1 | 0 | 1 |
| ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 4 | 0 | 5 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 4 | 2 | 7 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 3 | 0 | 3 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 1 | 6 |
| Mu-type opioid receptor | 0 | 6 | 1 | 10 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 4 | 1 | 6 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Protease | 0 | 5 | 0 | 5 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Histamine H4 receptor | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Envelope glycoprotein | 0 | 0 | 1 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
| Mu-type opioid receptor | 0 | 3 | 1 | 6 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| ClpP | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 3 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 2 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Histidine decarboxylase | 0 | 1 | 1 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 4 | 2 | 6 |
| Beta-3 adrenergic receptor | 0 | 2 | 2 | 4 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 2 | 5 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 4C | 0 | 2 | 0 | 2 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| MecA | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 0 | 0 | 2 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| GALC protein | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| XBP1 | 0 | 1 | 0 | 1 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| WD repeat-containing protein 48 | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |